Nara Recalls Infant Formula After 3 Botulism Cases

The UKHSA said it and partner agencies had received 36 clinical reports of children suffering symptoms consistent with toxin poisoning linked to recent baby formula recalls. PA

Nara Organics has voluntarily recalled all lots of its powdered infant formula currently on the market due to the potential risk of Clostridium botulinum contamination, according to a company announcement.

The infants, located in California, Washington, and Pennsylvania, were hospitalized and treated with BabyBIG, a specialized treatment for infant botulism. No deaths have been reported, according to a statement released Saturday by the U.S. Food and Drug Administration.